1% of Tramadol Ophthalmic Solution for Chronic Ocular Pain in Patients with Dry Eye: A prospective clinical study to examine the efficacy and safety

Not Applicable

• Conditions: Chronic Ocular Pain with Dry Eye

• Registration Number: JPRN-jRCTs011210050
• Lead Sponsor: Tagawa Yoshiaki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-11-17
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1)Patient aged 20 years or older on the date of informed consent
2)Patient with chronic ocular pain with dry eye for 3 months or over on the date of informed consent
3)Patient willing to participate in the clinical study with a fair understanding of the study content and when the informed consent is filled by the patient

Exclusion Criteria

1)Patient with severe hepatic disorder, renal disorder, vascular disorder, pulmonary disease, endocrine disease (includes diabetes mellitus) , mental illness (includes depression and anxiety disorder)
2)Patient with corneal erosion on the ocular surface, and corneal ulcer
3) Patient whose principal/sub investigator judged inappropriate for a study subject

Study & Design

• Study Type: Interventional
• Study Design: Not specified